SCHEMBL5729458

SCHEMBL5729458

O=CC1CCC(=O)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9206399 1.00
SCHEMBL4652897 1.00
SCHEMBL6259490 0.78
SCHEMBL16308846 0.75 CA1 (0.46)
SCHEMBL544336 0.73 CA1 (0.41)
SCHEMBL12834041 0.73
SCHEMBL21958195 0.70 CA1 (0.42)
SCHEMBL3699292 0.70 CA1 (0.38)
SCHEMBL14681131 0.69 CA1 (0.36)
SCHEMBL30886695 0.68 CYP1A2 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020082270-A1 Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-06-27 US claimed
US-20230321107-A1 THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE SERVIER PHARMACEUTICALS LLC 2023-10-12 US disclosed
CN-104170157-B Metal-air battery based on aluminum 亚利桑那董事会代表亚利桑那大学 2016-11-09 CN disclosed
CN-104170157-A Aluminum-based metal-air batteries UNIV ARIZONA 2014-11-26 CN disclosed
EP-1483271-B1 HETEROCYCLIC AMIDE DERIVATIVES HAVING GLYCOGEN PHOSPHORYLASE INHIBITORY ACTIVITY ASTRAZENECA AB (SE) 2006-11-22 EP disclosed
US-7138415-B2 Indolamid derivatives which possess glycogenphosphorylase inhibitory activity ASTRAZENECA AB (SE) 2006-11-21 US disclosed
US-7122567-B2 Heterocyclic amide derivatives having glycogen phosphorylase inhibitory activity ASTRAZENECA AB (SE) 2006-10-17 US disclosed
US-20050131052-A1 Heterocyclic amide derivatives having glycogen phosphorylase inhibitory activity ASTRAZENECA AB (SE) 2005-06-16 US disclosed
US-20050107362-A1 Indolamid derivatives which possess glycogenphosphorylase inhibitory activity ASTRA ZENECA AB (SE) 2005-05-19 US disclosed
EP-1483240-A1 INDOLAMID DERIVATIVES WHICH POSSESS GLYCOGEN PHOSPHORYLASE INHIBITORY ACTIVITY AstraZeneca AB (SE) 2004-12-08 EP disclosed
WO-2002051806-A1 CARBAZOLE DERIVATIVES AND THEIR USE AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS ASTRAZENECA AB (SE) 2002-07-04 WO disclosed
US-20020082270-A1 Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-06-27 US disclosed
CN-1044237-C 4,1-benzoxazep in derivatives and their use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1999-07-21 CN disclosed
EP-0602515-B1 Process for the preparation of 5-membered heterocycles BASF AG (DE) 1998-07-15 EP disclosed
EP-0408034-B1 3-Substituted vinyl cephalosporin derivatives EISAI CO LTD (JP) 1996-05-01 EP disclosed
US-5453516-A Furanones, pyrrolidones BASF AKTIENGESELLSCHAFT (DE) 1995-09-26 US disclosed
EP-0602515-A1 Process for the preparation of 5-membered heterocycles BASF Aktiengesellschaft (DE) 1994-06-22 EP disclosed
US-5151417-A Antibiotics and bactericides EISAI CO., LTD. (JP) 1992-09-29 US disclosed
CN-1048706-A 3-substituted vinyl cephalosporin derivatives and preparation method thereof EISAI CO LTD (JP) 1991-01-23 CN disclosed
EP-0408034-A1 3-Substituted vinyl cephalosporin derivatives Eisai Co., Ltd. (JP) 1991-01-16 EP disclosed